eticlopride has been researched along with yohimbine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Billings, J; Chumpradit, S; Kung, HF; Kung, MP; Mach, R | 1 |
| Chen, SF; Cheng, FC; Chung, LJ; Hsueh, CM; Huang, HJ; Kuo, JS; Lin, RJ | 1 |
| Kauer, JA; Mair, RD | 1 |
| Arencibia-Albite, F; Jiménez-Rivera, CA; Paladini, C; Williams, JT | 1 |
| Floresco, SB; Hosking, JG; Winstanley, CA | 1 |
| Bhat, S; Georgiou, P; Gould, TD; McCarthy, MM; Merchenthaler, IJ; Tracy, JK; Zanos, P | 1 |
6 other study(ies) available for eticlopride and yohimbine
| Article | Year |
|---|---|
Fluorinated and iodinated dopamine agents: D2 imaging agents for PET and SPECT.
Topics: Animals; Benzamides; Dopamine Agents; Dopamine D2 Receptor Antagonists; Fluorine Radioisotopes; Iodine Radioisotopes; Macaca fascicularis; Male; Pyrrolidines; Radionuclide Imaging; Rats; Rats, Sprague-Dawley; Tissue Distribution; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1993 |
Involvement of catecholamines in recall of the conditioned NK cell response.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amygdala; Animals; Atenolol; Brain Chemistry; Catecholamines; Cerebellum; Cerebral Cortex; Chromatography, High Pressure Liquid; Conditioning, Classical; Corpus Striatum; Dopamine; Dopamine Antagonists; Epinephrine; Female; Immunologic Memory; Killer Cells, Natural; Lymphocyte Activation; Mental Recall; Mice; Mice, Inbred BALB C; Norepinephrine; Oxathiins; Propanolamines; Salicylamides; Spleen; Yohimbine | 1999 |
Amphetamine depresses excitatory synaptic transmission at prefrontal cortical layer V synapses.
Topics: Adrenergic alpha-Antagonists; Amphetamine; Animals; Benzazepines; Central Nervous System Stimulants; Dopamine; Dopamine Antagonists; Drug Interactions; Electric Stimulation; Excitatory Postsynaptic Potentials; In Vitro Techniques; Methiothepin; Neural Inhibition; Neurons; Patch-Clamp Techniques; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Salicylamides; Serotonin Antagonists; Synapses; Synaptic Transmission; Yohimbine | 2007 |
Noradrenergic modulation of the hyperpolarization-activated cation current (Ih) in dopamine neurons of the ventral tegmental area.
Topics: Adrenergic alpha-Antagonists; Algorithms; Animals; Barium Compounds; Chlorides; Cyclic Nucleotide-Gated Cation Channels; Data Interpretation, Statistical; Dopamine; Dopamine Antagonists; Electrophysiology; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Male; Membrane Potentials; Neurons; Norepinephrine; Patch-Clamp Techniques; Potassium Channels; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Dopamine D2; Salicylamides; Ventral Tegmental Area; Yohimbine | 2007 |
Dopamine antagonism decreases willingness to expend physical, but not cognitive, effort: a comparison of two rodent cost/benefit decision-making tasks.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention; Cognition; Cost-Benefit Analysis; Decision Making; Dopamine; Dopamine Antagonists; Male; Models, Animal; Motivation; Neuropsychological Tests; Norepinephrine; Physical Exertion; Rats; Rats, Long-Evans; Reward; Salicylamides; Yohimbine | 2015 |
Dopamine and Stress System Modulation of Sex Differences in Decision Making.
Topics: Adrenergic alpha-2 Receptor Antagonists; Amygdala; Animals; Behavior, Animal; Decision Making; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Female; Male; Pyrimidines; Pyrroles; Quinpirole; Rats; Rats, Long-Evans; Receptors, Corticotropin-Releasing Hormone; Receptors, Dopamine D2; Salicylamides; Sex Characteristics; Yohimbine | 2018 |